Skip to main content
Clinical Trials/NCT04529655
NCT04529655
Completed
Not Applicable

Digital Capillary Refill for Monitoring of Sepsis

Oregon Health and Science University1 site in 1 country26 target enrollmentAugust 12, 2020
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Oregon Health and Science University
Enrollment
26
Locations
1
Primary Endpoint
Blood lactate Level
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

Observational study for monitoring of capillary refill time in sepsis

Detailed Description

This is an observational studying assessing changes in capillary refill time over the course of sepsis treatment.

Registry
clinicaltrials.gov
Start Date
August 12, 2020
End Date
November 1, 2023
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. David Sheridan

Assistant Professor of Emergency Medicine

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • Clinical evidence of a known or suspected infection and orders written for administration of IV antibiotics
  • Hypotension as defined by the need for any vasopressor (and 1 liter of fluid already administered) OR respiratory failure defined by assisted ventilation (includes mechanical ventilation and BIPAP), CPAP, or greater than or equal to 6 liters/minute of supplemental oxygen

Exclusion Criteria

  • No consent/inability to obtain consent from the participant or a legally authorized representative
  • Diagnosis of cirrhosis by medical chart review
  • Liver transplant recipient
  • AST or ALT greater than five times upper limit of normal
  • Diagnosis of ongoing chronic alcohol use disorder/abuse by chart review; if medical record unclear, use Appendix F
  • Clinical diagnosis of diabetic ketoacidosis or other condition such as profound hypoglycemia that requires hourly blood glucose monitoring
  • Hypersensitivity to Acetaminophen or Vitamin C
  • Patient, surrogate or physician not committed to full support (Exception: a patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest)
  • Home assisted ventilation (via tracheotomy or noninvasive) except for CPAP/BIPAP used only for sleep-disordered breathing
  • Current active kidney stone

Outcomes

Primary Outcomes

Blood lactate Level

Time Frame: during procedure

Correlation of Capillary refill to blood lactate

Secondary Outcomes

  • 28 day hospital mortality(28 days)
  • Vasoactive(24 hours)

Study Sites (1)

Loading locations...

Similar Trials